Neurowyzr: Difference between revisions

Line 1:

~~{{Draft}}~~

{{Infobox Startup

|logo=Neurowyzer-logo.png

Line 11:

Line 10:

|active_in=Australia, United States, India, Malaysia, Indonesia, Thailand, Vietnam, United Kingdom

}}

~~A brief overview of~~ {{PAGENAME}} ~~here~~

{{PAGENAME}} is a Singapore-based healthtech startup specializing in enhancing brain health and developing state-of-the-art technologies to mitigate early brain decline.

==Technology==

~~Describe~~ the ~~underlying science~~ and ~~technology~~ of ~~the startup here. Ideally, it should provide a layman introduction of any key differentiators and/or novel or proprietary scientific breakthroughs being commercialised by the startup.~~

The startup's first product is an online gamified digital neuroscience assessment that significantly reduces the time and dollar burden of traditional cognitive testing<ref name=":0">{{Cite web |last=Staff |first=TechNode Global |date=2023-08-24 |title=Singapore's Neurowyzr raises additional $2.1M in seed funding co-led by Jungle Ventures and Peak XV’s Surge |url=https://technode.global/2023/08/24/singapores-neurowyzr-raises-additional-2-1m-in-seed-funding-co-led-by-jungle-ventures-and-peak-xvs-surge/ |access-date=2025-12-05 |website=TNGlobal |language=en-US}}</ref>. This product has been notified with the respective regulatory bodies in Singapore, India, Malaysia, Indonesia, Thailand, Australia, Vietnam, United Kingdom and the United States.

==~~Intellectual Property~~==

~~The startup currently owns or licenses the following patents:~~

* '~~'Patent 1''~~

* ''Patent 2''

~~Participation~~ in ~~any technology transfer programmes may be worth describing here as well~~.

==~~Business Model~~==

~~Describe~~ the ~~startup's business model here~~, ~~with emphasis on any key differentiators or business model innovations~~.

==Traction==

~~List notable customers or partnerships here. Awards should not be listed here~~, ~~but under~~ "~~Accolades~~" ~~instead~~

Neurowyer's digital neuroscience assessment has been used across many of Singapore's health screening centers, general practitioners (GP) clinics, community care, and specialist centers, including Parkway Shenton, SATA Commhealth, Farrer Park Hospital, MHC Medical Centre (Amara), and O’Joy<ref name=":0" />.

=~~=Accolades==~~

It has also been piloted in one of India's largest private hospital chains<ref name=":0" />.

~~List awards received by the startup here~~.

==Funding==

~~Describe the startup's funding history here. Include investors in the table below~~.{{Startup/Funding history}}

In 2023, Neurowyzer raised a seed round lead by Jungle Ventures and Peak XV’s Surge<ref name=":0" />.{{Startup/Funding history}}

~~== See also ==~~

* List any other pages directly relevant to {{PAGENAME}}

== References ==

@@ Line 1: / Line 1: @@
-{{Draft}}
 {{Infobox Startup
 |logo=Neurowyzer-logo.png
@@ Line 11: / Line 10: @@
 |active_in=Australia, United States, India, Malaysia, Indonesia, Thailand, Vietnam, United Kingdom
 }}
-A brief overview of {{PAGENAME}} here
+{{PAGENAME}} is a Singapore-based healthtech startup specializing in enhancing brain health and developing state-of-the-art technologies to mitigate early brain decline.
 ==Technology==
-Describe the underlying science and technology of the startup here. Ideally, it should provide a layman introduction of any key differentiators and/or novel or proprietary scientific breakthroughs being commercialised by the startup.
+The startup's first product is an online gamified digital neuroscience assessment that significantly reduces the time and dollar burden of traditional cognitive testing<ref name=":0">{{Cite web |last=Staff |first=TechNode Global |date=2023-08-24 |title=Singapore's Neurowyzr raises additional $2.1M in seed funding co-led by Jungle Ventures and Peak XV’s Surge |url=https://technode.global/2023/08/24/singapores-neurowyzr-raises-additional-2-1m-in-seed-funding-co-led-by-jungle-ventures-and-peak-xvs-surge/ |access-date=2025-12-05 |website=TNGlobal |language=en-US}}</ref>. This product has been notified with the respective regulatory bodies in Singapore, India, Malaysia, Indonesia, Thailand, Australia, Vietnam, United Kingdom and the United States.
-==Intellectual Property==
-The startup currently owns or licenses the following patents:
-* ''Patent 1''
-* ''Patent 2''
-Participation in any technology transfer programmes may be worth describing here as well.
-==Business Model==
-Describe the startup's business model here, with emphasis on any key differentiators or business model innovations.
 ==Traction==
-List notable customers or partnerships here. Awards should not be listed here, but under "Accolades" instead
+Neurowyer's digital neuroscience assessment has been used across many of Singapore's health screening centers, general practitioners (GP) clinics, community care, and specialist centers, including Parkway Shenton, SATA Commhealth, Farrer Park Hospital, MHC Medical Centre (Amara), and O’Joy<ref name=":0" />.
-==Accolades==
+It has also been piloted in one of India's largest private hospital chains<ref name=":0" />.
-List awards received by the startup here.
 ==Funding==
-Describe the startup's funding history here. Include investors in the table below.{{Startup/Funding history}}
+In 2023, Neurowyzer raised a seed round lead by Jungle Ventures and Peak XV’s Surge<ref name=":0" />.{{Startup/Funding history}}
-== See also ==
-* List any other pages directly relevant to {{PAGENAME}}
 == References ==
 {{Reflist}}